Table of Contents

company-logo

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.

Dermata Therapeutics Dividend Announcement

• Dermata Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Dermata Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Dermata Therapeutics Dividend History

Dermata Therapeutics Dividend Yield

Dermata Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Dermata Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Dermata Therapeutics Financial Ratios

P/E ratio-0.18
PEG ratio0.01
P/B ratio0.44
ROE-247.40%
Payout ratio0.00%
Current ratio3.44
Quick ratio3.44
Cash Ratio3.16

Dermata Therapeutics Dividend FAQ

Does Dermata Therapeutics stock pay dividends?
Dermata Therapeutics does not currently pay dividends to its shareholders.
Has Dermata Therapeutics ever paid a dividend?
No, Dermata Therapeutics has no a history of paying dividends to its shareholders. Dermata Therapeutics is not known for its dividend payments.
Why doesn't Dermata Therapeutics pay dividends?
There are several potential reasons why Dermata Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Dermata Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Dermata Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Dermata Therapeutics a dividend aristocrat?
Dermata Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Dermata Therapeutics a dividend king?
Dermata Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Dermata Therapeutics a dividend stock?
No, Dermata Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Dermata Therapeutics stocks?
To buy Dermata Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Dermata Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.